Citius Oncology, Inc. CTOR Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s net income?
- Citius Oncology, Inc. (CTOR) reported net income of -$26.61M in Q1 2026.
- How has Citius Oncology, Inc.'s net income changed year-over-year?
- Citius Oncology, Inc.'s net income decreased by 244.0% year-over-year, from -$7.74M to -$26.61M.
- What is the long-term trend for Citius Oncology, Inc.'s net income?
- Over 2 years (2023 to 2025), Citius Oncology, Inc.'s net income has grown at a 39.6% compound annual growth rate (CAGR), from -$12.7M to -$24.76M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.